Devices · V5med Inc.

V5med Lung AI

V5med Inc. is listed for V5med Lung AI (K242919). The FDA list gives March 27, 2025 as the date of the final decision. The lead panel is Radiology, and the database link on the FDA list is the 510(k) pathway. openFDA describes product code OEB as “Lung Computed Tomography System, Computer-Aided Detection”: To assist radiologists in the review of multi-slice computed tomography (msct) exams of the chest and highlight potential nodules that the radiologist should review. A computer aided diagnosis, lung computed tomography system is a class 3 device under product code NRR. openFDA records this submission’s decision description as “Substantially Equivalent.” This paragraph is assembled only from those public fields. It is not an FDA review, not a determination of safety or effectiveness, and not medical advice. Official record: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K242919

Official FDA database record

Date of final decision

March 27, 2025

Company on the FDA list

V5med Inc.

Lead panel

Radiology

Primary product code

OEB

openFDA device name for the code

Lung Computed Tomography System, Computer-Aided Detection

Device class

2

Regulation number

892.2050

openFDA decision description

Substantially Equivalent

openFDA decision code

SESE

Statement or summary label

Summary